Dr. Moncef Slaoui speaks with President Donald J. Trump about Operation Warp Speed ​​in the Rose Garden of the White House on Friday November 13, 2020 in Washington, DC.

Jabin Botsford | The Washington Post | Getty Images

Moncef Slaoui, who led the development of the Covid vaccine Operation Warp Speed ​​during the Trump administration, was sacked on Wednesday as chairman of the board of directors of Galvani Bioelectronics on allegations of sexual harassment.

Slaoui’s dismissal, announced by the board of directors of Galvani majority shareholder GlaxoSmithKline, came after receipt of a letter from the company that “included allegations of sexual harassment and inappropriate behavior by Dr. Slaoui against an employee of GSK, which occurred at his home a few years ago.” GSK employees, “said Glaxo.

“After receiving the letter, the GSK board immediately launched an investigation into an experienced law firm to investigate the allegations,” said the GSK statement. “The investigation into Dr. Slaoui’s behavior has substantiated the allegations and is ongoing.”

GSK said in its statement: “Dr. Slaoui’s behavior is completely unacceptable.”

“They represent an abuse of his leadership position, violate company guidelines and contradict the strong values ​​that define GSK’s culture,” the statement said. “The company expects everyone at GSK to behave according to their values, especially their executives, who have the highest standards. Sexual harassment and abuse of leadership positions are strictly prohibited and will not be tolerated.”

This is the latest news. Please try again.